Company intelligence / Profile preview

Centre for Imaging Technology Commercialization

London, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

CIMTEC is not a therapeutic developer but has supported commercialization of imaging technologies, indirectly contributing to multiple devices used for cancer diagnosis and neurodegenerative disease care. Its spin-off Focal Healthcare is developing MRI-Ultrasound Fusion Biopsy and Therapy systems for prostate cancer.

Therapeutic areas: OncologyNeurology
Modalities: Device
Industry: Consulting

Partnerships

Canadian academic centersEarly-stage medical device companies

Beyond the preview

Go deeper on Centre for Imaging Technology Commercialization.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Centre for Imaging Technology Commercialization.

Explore the full profile